Skip to main content
. 2016 May 5;2016(5):CD001240. doi: 10.1002/14651858.CD001240.pub3

Gathwala 2011.

Methods Single‐center open label, randomized controlled trial in India
Participants Included 72 full term neonates (all inborn) with severe perinatal asphyxia (cord blood pH < 7 and Apgar score ≤ 5 at 5 minutes) without obvious congenital malformation
Interventions Phenobarbital group (n = 36) received a phenobarbital loading dose (40 mg/kg IV infusion over 60 minutes) within the first 2 hours of life, followed by conventional therapy per unit protocol for HIE. Heart rate, oxygen saturation, respiration, and mean arterial pressure were monitored continuously during administration of phenobarbital
Control group (n = 36) were managed with conventional therapy per unit protocol for the management of HIE
Outcomes Primary outcome: CSF levels of lipid peroxides (MDA) and antioxidant enzymes (SOD and GPx) at 12 ± 2 hours of life
Secondary outcomes: death, seizure activity, neurologic exam at discharge and neurologic outcome at 1‐month follow‐up (based on neurologic exam, MRI and EEG results)
HIE staging for each infant according to the criteria of Sarnat and Sarnat
Cranial ultrasounds on day 3 and day 7 of life
Adverse effects of phenobarbital administration
Notes Reported on seizure duration. Incidence data was requested without response from the authors
There were no specific data given for the number of infants from each group with neonatal seizures. The authors stated that the incidence of neonatal seizures was comparable in the phenobarbital group and the control group
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Random number table
Allocation concealment (selection bias) Low risk Random number sequences were placed in sealed envelopes and opened following infants resuscitation if selection criteria met
Blinding (performance bias and detection bias) 
 All outcomes High risk There was no blinding of the treatment team or assessors. No placebo was used
Incomplete outcome data (attrition bias) 
 All outcomes Low risk 1‐month follow‐up: 2/32 (6%) living infants missing from the intervention group, 0/30 (0%) living infants missing for the control group
Selective reporting (reporting bias) Low risk All outcomes were reported